(56 days)
Not Found
No
The 510(k) summary describes a physical mask accessory for CPAP/bilevel therapy and does not mention any software, algorithms, or AI/ML capabilities.
No
The device is a mask, which is an accessory used with therapeutic devices (CPAP and bilevel devices) but is not a therapeutic device itself.
No.
Explanation: This device is a respiratory mask used to deliver continuous positive airway pressure or bilevel therapy, which is a treatment method, not a diagnostic one.
No
The device description clearly outlines physical components (mask, frame, cushion, cushion clip, tubing) and its function as a hardware interface for CPAP/bilevel devices. There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Hospital Full Face Mask is a physical interface used to deliver positive pressure ventilation to a patient's lungs. It does not involve testing samples from the body.
- Intended Use: The intended use clearly states it's for delivering CPAP or bilevel therapy, which is a treatment method, not a diagnostic test.
Therefore, the device described is a medical device used for therapy, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Hospital Full Face Mask is intended for single patient use for adult patients (>30 Kg) prescribed continuous positive airway pressure or bilevel therapy in hospitals or clinics. This is a disposable mask. It is intended to be used for the short-term (maximum 7 days) treatment of a single patient only, then discarded.
Product codes
BZD
Device Description
The Hospital Full Face Mask is a respirator mask covering the nose and the mouth. It is a patient interface accessory for use with CPAP and bilevel devices.
The Hospital Full Face Mask is strapped to the patient's face covering the nose and mouth. It is connected via tubing to a CPAP or bilevel flow generator. Positive pressure ventilation is thus applied to the lungs in a non-invasive way. The Hospital Full Face Mask comes in 3 sizes, small, medium and large. Each size comprises a frame, cushion and cushion clip.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Face (nose and mouth)
Indicated Patient Age Range
adult patients (>30 Kg)
Intended User / Care Setting
hospitals or clinics
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing is provided to demonstrate that the Hospital Full Face mask is substantially equivalent to the Full Face Mask series 2. The original testing that was performed for the Full Face Mask Series 2 was reviewed as an input to the selected test methods. This testing provided represents ResMed's state of the art knowledge and procedures.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K023244: Mirage Full Face Mask Series 2
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/2 description: The image shows a handwritten text string. The string appears to be "Kou1362". The text is written in a cursive style with some characters connected.
510(k) SUMMARY—Hospital Full Face Mask
| Submitter Name: | ResMed Ltd |
|---|---|
| Submitter Address: | 97 Waterloo Road, North Ryde NSW 2113, Australia |
| Contact Person: | David D'Cruz, VP Regulatory & Clinical Affairs US |
| Phone Number: | (858) 746 2238 |
| Fax Number: | (858) 746 2915 |
| Date Prepared: | May 17, 2004 |
| Device Trade Name: | ResMed Hospital Full Face Mask |
| Device Common Name/ | |
| Classification Name: | Full Face Mask |
| Predicate Devices: | K023244: Mirage Full Face Mask Series 2 |
| Device Description: | The Hospital Full Face Mask is a respirator mask covering the |
| nose and the mouth. It is a patient interface accessory for use | |
| with CPAP and bilevel devices. | |
| Intended Use: | The Hospital Full Face Mask is intended for single patient use |
| for adult patients (>30 Kg) prescribed continuous positive | |
| airway pressure or bilevel therapy in hospitals or clinics. | |
| This is a disposable mask. It is intended to be used for the | |
| short-term (maximum 7 days) treatment of a single patient | |
| only, then discarded. |
1
Device Technological Characteristics and Comparison to Predicate Device(s):
The Hospital Full Face Mask is strapped to the patient's face covering the nose and mouth. It is connected via tubing to a CPAP or bilevel flow generator. Positive pressure ventilation is thus applied to the lungs in a non-invasive way.
The Hospital Full Face Mask comes in 3 sizes, small, medium and large. Each size comprises a frame, cushion and cushion clip.
The Hospital Full Face Mask is substantially equivalent to the Mirage Full Face Mask Series 2. The two masks have a substantially equivalent intended use (Hospital Full Face Mask for single patient use only), same operating principle, same technological characteristics and same manufacturing process. The Mirage Full Face Mask is cleared for multi patient multi use. The Hospital Full Face Mask is for single patient multiple use only.
Performance Data:
Testing is provided to demonstrate that the Hospital Full Face mask is substantially equivalent to the Full Face Mask series 2. The original testing that was performed for the Full Face Mask Series 2 was reviewed as an input to the selected test methods. This testing provided represents ResMed's state of the art knowledge and procedures.
Materials Biocompatibility
The materials used for the mask components, which contact the skin and/or the air-path, are either predicate materials (i.e., cleared previously for the same intended use), are in compliance with ISO10993-1 or have been submitted to an independent accredited laboratory for conformance to ISO10993-1. ResMed has procedures in place to ensure that the ISO10993-1 test results are reviewed and accepted prior to implementation and release of the material for use in producing masks products.
Conclusion:
The Hospital Full Face Mask is substantially equivalent to the Mirage Full Face Mask Series 2. The changes in design do not affect safety and effectiveness of the Hospital Full Face Mask.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a series of flowing lines, possibly representing the interconnectedness of health and human services.
Public Health Service
JUL 1 5 2004
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
ResMed Limited C/O Mr. David D' Cruz Vice President, Regulatory & Clinical Affairs ResMed Corporation 14040 Danielson Street Poway, California 92064-6857
Re: K041362
Trade/Device Name: ResMed Hospital Full Face Mask Regulation Number: 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: May 17, 2004 Received: May 20, 2004
Dear Mr. D' Cruz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 -Mr. D' Cruz
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Suva Runne
fz Chiu Lin, Ph.D.
Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K041362
Device Name: ResMed Hospital Full Face Mask
Indications for Use:
The Hospital Full Face Mask is intended for single patient use for adult patients (>30 Kg) prescribed continuous positive airway pressure or bilevel therapy in hospitals or clinics.
This is a disposable mask. It is intended to be used for the short-term (maximum 7 days) treatment of a single patient only, then discarded.
Prescription Use _ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Auy Sylum
(Division Signesiology, General Hospital Infection
510(k) Number: K041362
Page 1 of_____________________________________________________________________________________________________________________________________________________________________